1. Medtech Insight
  2. >>Device Area
  3. >>Cardiology

SCAI2018: New Study Shows 3D Printing Helps Prevent Leaks In Heart-Valve Patients

 
• By Marion Webb

The clinical use of 3D printing got a boost when interventional cardiologists presented data at the annual meeting of The Society for Cardiovascular Angiography and Interventions that supported th4 technology's effectiveness in helping to predict paravalvular leak in patients undergoing transcatheter aortic valve replacement. The implantation of an ill-fitting valve that can lead to paravalvular leak is a common risk of TAVR procedures.

Two female hands holding a 3d printed human heart

Data from a new study that evaluated the effectiveness of 3D printing and computer modeling in predicting paravalvular leak (PVL) in patients undergoing transcatheter aortic valve replacement (TAVR) has backed the use of the technology for addressing the problem of ill-fitting valves. The data was presented on April 26 at the 41st annual Society for Cardiovascular Angiography and Interventions (SCAI) meeting, which is being held in San Diego through April 28. 

In the study, six patients undergoing TAVR for severe calcific aortic stenosis and at risk for PVL had pre-procedure computed...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Cardiology

Boston Scientific Raises Outlook … Again: Headwinds Offset By EP And Watchman

 
• By Natasha Barrow

Agent drug coated balloon, Watchman product sales, and electrophysiology (EP) business unit growth offset Acurate discontinuation and tariff headwinds. CEO Michael Mahoney shouted out coronary therapies business and answered questions on CMS proposed Ambulatory Surgical Center codes.

Injuries And Deaths Linked To Baxter Infusion Pump

 
• By Brian Bossetta

The US FDA says Baxter has notified customers about an issue with its Novum IQ Syringe Pump that is linked to two deaths and multiple injuries.

HeartFlow Takes Another Crack At Public Markets With $100M IPO Filing

 
• By Marion Webb

AI heart imaging company HeartFlow filed for a $100m IPO after scrapping its 2022 SPAC plans. It remains unprofitable but is betting on FDA clearances, Medicare coverage and a demand for AI-powered diagnostics to win over investors.

Abbott Lowers Outlook But Headwinds Are Temporary

 
• By Natasha Barrow

Despite headwinds, executives remain optimistic about growth in Abbott’s medical devices and diabetes divisions and plan several product rollouts, including the Volt PFA catheter for electrophysiology and the dual glucose-ketone sensor CGM.

More from Device Area

ForSight Sets Its Sights On Automating Delicate Eye Procedures

 
• By Marion Webb

ForSight Robotics is developing a robotic platform to automate cataract and other eye surgeries, aiming to ease surgeon strain and expand access. Backed by $200m in total funding, it's targeting a first human surgery using Oryom by year-end and is in discussions with US FDA.

Injuries And Deaths Linked To Baxter Infusion Pump

 
• By Brian Bossetta

The US FDA says Baxter has notified customers about an issue with its Novum IQ Syringe Pump that is linked to two deaths and multiple injuries.

Private Equity Firm Archimed To Buy ZimVie As Antitrust Concerns Sideline Strategic Buyers

 
• By Marion Webb

Archimed will acquire dental implant firm ZimVie for $730m in a deal that reflects private equity’s growing role in medtech M&A, as strategic buyers face antitrust scrutiny. The deal includes a 125% premium and a 40-day window for competing offers.